We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ONCY market cap is 78.89M. The company's latest EPS is CAD -0.3659 and P/E is -2.76.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -6.73M | -7.16M | -11.05M | -8.85M | -8.73M |
| Net Income | -6.44M | -7.44M | -9.93M | -3.95M | -6.89M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -20.14M | -25.46M | -26.23M | -26.92M | -33.79M |
| Net Income | -33.12M | -22.51M | -26.3M | -24.84M | -27.75M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 35.33M | 31.97M | 46.09M | 38.82M | 34.75M |
| Total Liabilities | 9.58M | 9.73M | 17.07M | 11.26M | 11.78M |
| Total Equity | 25.75M | 22.24M | 29.02M | 27.56M | 22.97M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 19.66M | 34.35M | 45.88M | 37.33M | 38.82M |
| Total Liabilities | 19.77M | 9.59M | 9.78M | 10.83M | 11.26M |
| Total Equity | -108k | 24.75M | 36.1M | 26.5M | 27.56M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -7.83M | -16.29M | -22.32M | -28.45M | -7.47M |
| Investing | 6.67M | 13.46M | 20.23M | 20.22M | -46k |
| Financing | 5.27M | 8.96M | 30.25M | 31.99M | 1.5M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -19.91M | -22.07M | -22.44M | -23.36M | -28.45M |
| Investing | -11k | -29k | -286k | -20.4M | 20.22M |
| Financing | 21.02M | 39.77M | 33.02M | 12.21M | 31.99M |
| Market Cap | 78.89M |
| Price to Earnings Ratio | -2.76 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.19 |
| Price to Book Ratio | 2.78 |
| Dividend Yield | - |
| Shares Outstanding | 75.85M |
| Average Volume (1 week) | 145k |
| Average Volume (1 Month) | 191.37k |
| 52 Week Change | -65.68% |
| 52 Week High | 3.37 |
| 52 Week Low | 0.883 |
| Spread (Intraday) | 0.06 (5.77%) |
| Company Name | Oncolytics Biotech Inc |
| Address |
1167 kensington crescent nw, suite 210 calgary, alberta T2N 1X7 |
| Website | https://www.oncolyticsbiotech.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
